Clinical Trial Update: Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes an extension study of Idursulfase-IT in combination with Elaprase for children and adults with Hunter syndrome and cognitiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Elaprase (idursulfase)
• Idursulfase-IT (idursulfase-IT)

Snippet

Sponsor: Takeda | Conditions: Hunter Syndrome | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING